Andrew D. Trister, Ph.D. - Publications

2007 University of Pennsylvania, Philadelphia, PA, United States 
cell adhesion and motility

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Sponseller P, Pelly N, Trister A, Ford E, Ermoian R. Radiation treatment for the right naris in a pediatric anesthesia patient using an adaptive oral airway technique Medical Dosimetry. 40: 201-204. PMID 25619555 DOI: 10.1016/j.meddos.2014.11.006  0.88
2015 Gensheimer MF, Hawkins DS, Ermoian RP, Trister AD. Assessing the scale of tumor heterogeneity by complete hierarchical segmentation of MRI. Physics in Medicine and Biology. 60: 977-93. PMID 25575341 DOI: 10.1088/0031-9155/60/3/977  0.88
2015 Dhami G, Gao W, Trister AD. Diversity matters: historical lessons. Journal of the American College of Radiology : Jacr. 12: 118-9. PMID 25557579 DOI: 10.1016/j.jacr.2014.09.023  0.88
2015 Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. Journal of the Royal Society, Interface / the Royal Society. 12. PMID 25540239 DOI: 10.1098/rsif.2014.1174  0.88
2015 Mikheev AM, Mikheeva SA, Trister AD, Tokita MJ, Emerson SN, Parada CA, Born DE, Carnemolla B, Frankel S, Kim DH, Oxford RG, Kosai Y, Tozer-Fink KR, Manning TC, Silber JR, et al. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. Neuro-Oncology. 17: 372-82. PMID 25140038 DOI: 10.1093/neuonc/nou161  0.88
2014 Trister A, Scott J, Rockne R, Yagle K, Johnston SK, Hawkins-Daarud A, Baldock A, Swanson KR. Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas". Neuro-Oncology. 16: 1670-1. PMID 25398942 DOI: 10.1093/neuonc/nou290  0.88
2014 Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, et al. Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas. Plos One. 9: e99057. PMID 25350742 DOI: 10.1371/journal.pone.0099057  0.88
2014 Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, et al. Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro-Oncology. 16: 779-86. PMID 24832620 DOI: 10.1093/neuonc/nou027  0.88
2014 Trister AD, Pryma DA, Xanthopoulos E, Kucharczuk J, Sterman D, Rengan R. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer. American Journal of Clinical Oncology. 37: 135-9. PMID 23111361 DOI: 10.1097/COC.0b013e31826b9cd3  0.88
2013 Corwin D, Holdsworth C, Rockne RC, Trister AD, Mrugala MM, Rockhill JK, Stewart RD, Phillips M, Swanson KR. Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma. Plos One. 8: e79115. PMID 24265748 DOI: 10.1371/journal.pone.0079115  0.88
2013 Ferté C, Trister AD, Huang E, Bot BM, Guinney J, Commo F, Sieberts S, André F, Besse B, Soria JC, Friend SH. Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4315-25. PMID 23780890 DOI: 10.1158/1078-0432.CCR-12-3937  0.88
2013 Baldock AL, Rockne RC, Boone AD, Neal ML, Hawkins-Daarud A, Corwin DM, Bridge CA, Guyman LA, Trister AD, Mrugala MM, Rockhill JK, Swanson KR. From patient-specific mathematical neuro-oncology to precision medicine. Frontiers in Oncology. 3: 62. PMID 23565501 DOI: 10.3389/fonc.2013.00062  0.88
2013 Trister AD, Huang ES. A network-heuristic approach to improve the impact of genomic data on drug discovery. Clinical Pharmacology and Therapeutics. 93: 295-7. PMID 23511782 DOI: 10.1038/clpt.2012.246  0.88
2013 Neal ML, Trister AD, Ahn S, Baldock A, Bridge CA, Guyman L, Lange J, Sodt R, Cloke T, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression. Cancer Research. 73: 2976-86. PMID 23400596 DOI: 10.1158/0008-5472.CAN-12-3588  0.88
2013 Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric. Plos One. 8: e51951. PMID 23372647 DOI: 10.1371/journal.pone.0051951  0.88
2012 Holdsworth CH, Corwin D, Stewart RD, Rockne R, Trister AD, Swanson KR, Phillips M. Adaptive IMRT using a multiobjective evolutionary algorithm integrated with a diffusion-invasion model of glioblastoma. Physics in Medicine and Biology. 57: 8271-83. PMID 23190554 DOI: 10.1088/0031-9155/57/24/8271  0.88
2012 Trister A, Patel S. The use of tamoxifen in an estrogen-independent manner for various neoplasms Tamoxifen Concepts and Cancer: New Paradigms. 87-93.  0.88
2008 Trister AD, Hammer DA. Role of gp120 trimerization on HIV binding elucidated with Brownian adhesive dynamics. Biophysical Journal. 95: 40-53. PMID 18339756 DOI: 10.1529/biophysj.107.118430  0.88
Show low-probability matches.